{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:51:32Z","timestamp":1780066292572,"version":"3.54.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ijrobp.2008.12.047","type":"journal-article","created":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T13:00:33Z","timestamp":1240318833000},"page":"1013-1020","source":"Crossref","is-referenced-by-count":31,"title":["Hypofractionated Intensity-Modulated Arc Therapy for Lymph Node Metastasized Prostate Cancer"],"prefix":"10.1016","volume":"75","author":[{"given":"Val\u00e9rie","family":"Fonteyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"De Gersem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"De Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas","family":"Lumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Vandecasteele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Villeirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"De Meerleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2008.12.047_bib1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.ju.0000095025.03331.c6","article-title":"CaPSURE: Time trends in clinical risk stratification for prostate cancer: Implications for outcomes (data from CaPSURE)","volume":"170","author":"Cooperberg","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib2","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.1200\/JCO.2005.02.9751","article-title":"The changing face of prostate cancer","volume":"23","author":"Cooperberg","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib4","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0360-3016(02)02857-2","article-title":"High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients","volume":"53","author":"Zelefsky","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib6","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ju.0000111844.95024.74","article-title":"Prostate cancer radiotherapy dose response: An update of the Fox Chase experience","volume":"171","author":"Pollack","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RTO1 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijrobp.2007.06.067","article-title":"(125)I monotherapy using D90 implant doses of 180 Gy or greater","volume":"70","author":"Kao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.juro.2007.10.067","article-title":"3-Year actuarial biochemical recurrence-free survival following laparoscopic radical prostatectomy: Experience from a tertiary referral center in the United States","volume":"179","author":"Pavlovich","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<764::AID-CNCR16>3.0.CO;2-R","article-title":"Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation","volume":"80","author":"Zagars","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib11","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/1097-0142(19920601)69:11<2761::AID-CNCR2820691122>3.0.CO;2-K","article-title":"Is long-term survival with external beam irradiation for stage D1 adenocarcinoma of the prostate?","volume":"69","author":"Lawton","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0360-3016(96)00590-1","article-title":"Stage T1-T2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy","volume":"37","author":"Kupelian","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0360-3016(97)00288-5","article-title":"Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31)","volume":"38","author":"Colleen","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0360-3016(97)00369-6","article-title":"The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer","volume":"39","author":"Whittington","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0360-3016(02)02868-7","article-title":"Long-term use of combined radiation therapy and hormonal therapy in the management of stage D1 prostate cancer","volume":"53","author":"Robnett","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0360-3016(02)02977-2","article-title":"Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: Analysis of a prostate cancer randomized radiation dose escalation trial","volume":"54","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cncr.11927","article-title":"The relationship of increasing radiotherapy dose to reduced distant metastasis and mortality in men with prostate cancer","volume":"100","author":"Jacob","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0360-3016(00)00620-9","article-title":"External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era","volume":"48","author":"Pollack","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib19","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2002.01.086","article-title":"Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases","volume":"20","author":"Coen","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijrobp.2005.02.050","article-title":"Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity modulated radiotherapy","volume":"63","author":"Ashman","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2007.07.013","article-title":"Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer","volume":"84","author":"Cozzarini","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2006.12.007","article-title":"Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control","volume":"82","author":"De Meerleer","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0360-3016(00)00419-3","article-title":"Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison","volume":"47","author":"De Meerleer","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2004.04.016","article-title":"Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer","volume":"60","author":"Duthoy","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(01)01651-0","article-title":"A simple analytic derivation suggests that prostate cancer \u03b1\/\u03b2 ratio is low","volume":"51","author":"King","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumours show high sensitivity to fractionation (low alpha\/beta ratio), similar to late responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib28","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0360-3016(03)01455-X","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"57","author":"Kal","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib29","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionation intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.06.011","article-title":"Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area","volume":"84","author":"Arcangeli","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2006.06.005","article-title":"Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial","volume":"66","author":"Yeoh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2005.07.970","article-title":"Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial","volume":"64","author":"Pollack","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijrobp.2008.01.040","article-title":"Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with a simultaneous integrated boost on the intraprostatic lesion","volume":"72","author":"Fonteyne","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0360-3016(94)90138-4","article-title":"Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer","volume":"28","author":"Roach","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib35","series-title":"Manual for staging of cancer","year":"1997"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2005.04.014","article-title":"The magnetic resonance detected intraprostatic lesion in prostate cancer: Planning and delivery of intensity-modulated radiotherapy","volume":"75","author":"De Meerleer","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijrobp.2004.04.017","article-title":"Intensity-modulated radiotherapy as primary therapy for prostate cancer: Acute toxicity in 114 patients","volume":"60","author":"De Meerleer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2007.06.013","article-title":"Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: The need for adapting toxicity scales","volume":"84","author":"Fonteyne","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0022-5347(17)56712-9","article-title":"Prostatic lymphography","volume":"121","author":"Raghavaiah","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-5347(17)59483-5","article-title":"An evaluation of lymphangiography in staging carcinoma of prostate","volume":"113","author":"Cerny","year":"1975","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0090-4295(00)00921-3","article-title":"Lymphatic drainage of prostatic transition and peripheral zones visualized on a three-dimensional workstation","volume":"57","author":"Brossner","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib42","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0360-3016(03)00663-1","article-title":"Whole abdominopelvic radiotherapy (WAPRT) using intensity modulated arc therapy (IMAT): First clinical experience","volume":"58","author":"Duthoy","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00066-004-1209-2","article-title":"Direct segmentation aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer","volume":"180","author":"De Meerleer","year":"2004","journal-title":"Strahlenther Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib44","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib45","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0360-3016(97)00288-5","article-title":"Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31)","volume":"38","author":"Lawton","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib46","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2006.05.037","article-title":"Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer","volume":"66","author":"Wang-Chesebro","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00066-006-1586-9","article-title":"Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?","volume":"182","author":"Sanguineti","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-3-1","article-title":"Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer","author":"Yuen","year":"2008","journal-title":"Radiother Oncol Epub"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0360-3016(99)00560-X","article-title":"Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response","volume":"47","author":"Skwarchuk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0360-3016(02)02836-5","article-title":"Preliminary observations on biochemical relapse-free survival after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy\/fraction) for localized prostate cancer","volume":"53","author":"Kupelian","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0360-3016(96)00580-9","article-title":"Low acute gastrointestinal and genitourinary toxicities in whole pelvic irradiation of prostate cancer","volume":"38","author":"Liu","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib52","first-page":"1","article-title":"Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: Observations of a randomized trial","volume":"73","author":"Koper","year":"2004","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib53","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.10.5171","article-title":"Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01","volume":"34","author":"Pommier","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.12.047_bib54","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2007.11.060","article-title":"Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences","volume":"71","author":"Muren","year":"2008","journal-title":"Int J Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T16:05:59Z","timestamp":1558281959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0360301609000157"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.047","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}